Clinical Trial Update: Lobradimil and Carboplatin in Treating Children With Brain Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of lobradimil and carboplatin for children with brain or central nervous system tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Central Nervous System Tumors

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Lobradimil (lobradimil)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED